AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 223 filers reported holding AMICUS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,486,144 | -3.2% | 2,095,900 | 0.0% | 1.88% | -7.4% |
| Q2 2023 | $26,324,504 | +13.3% | 2,095,900 | 0.0% | 2.03% | +32.6% |
| Q1 2023 | $23,243,531 | -9.2% | 2,095,900 | 0.0% | 1.53% | -4.0% |
| Q4 2022 | $25,590,939 | +16.7% | 2,095,900 | -0.2% | 1.60% | +52.9% |
| Q3 2022 | $21,924,000 | -22.5% | 2,100,000 | -20.3% | 1.04% | -25.0% |
| Q2 2022 | $28,300,000 | +16.7% | 2,635,000 | +2.9% | 1.39% | +9.0% |
| Q1 2022 | $24,245,000 | -18.0% | 2,560,211 | 0.0% | 1.28% | -8.6% |
| Q4 2021 | $29,570,000 | +20.9% | 2,560,211 | 0.0% | 1.40% | +10.7% |
| Q3 2021 | $24,450,000 | +26.9% | 2,560,211 | +28.1% | 1.26% | +48.1% |
| Q2 2021 | $19,260,000 | -0.7% | 1,997,880 | +1.8% | 0.85% | +6.6% |
| Q1 2021 | $19,393,000 | -50.1% | 1,962,880 | +16.5% | 0.80% | -52.0% |
| Q4 2020 | $38,902,000 | +18.8% | 1,684,795 | -27.4% | 1.67% | +2.6% |
| Q3 2020 | $32,759,000 | -6.4% | 2,320,026 | 0.0% | 1.63% | -28.0% |
| Q2 2020 | $34,986,000 | +63.2% | 2,320,026 | 0.0% | 2.26% | +57.9% |
| Q1 2020 | $21,437,000 | -5.0% | 2,320,026 | +0.1% | 1.43% | -1.6% |
| Q4 2019 | $22,576,000 | +21.4% | 2,317,870 | 0.0% | 1.45% | -54.3% |
| Q3 2019 | $18,589,000 | -35.7% | 2,317,870 | 0.0% | 3.18% | -21.4% |
| Q2 2019 | $28,927,000 | +13.9% | 2,317,870 | +24.1% | 4.05% | +7.8% |
| Q1 2019 | $25,403,000 | +42.0% | 1,867,870 | 0.0% | 3.76% | +49.2% |
| Q4 2018 | $17,894,000 | -10.2% | 1,867,870 | +13.4% | 2.52% | +59.2% |
| Q3 2018 | $19,923,000 | +18.0% | 1,647,870 | +52.4% | 1.58% | -6.8% |
| Q2 2018 | $16,888,000 | – | 1,081,181 | – | 1.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |